share_log

UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection

UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection

更新：辉瑞-BioNTech表示，请求是基于12至15岁青少年关键阶段3期试验的数据，无论之前有没有SARS-CoV-2感染的证据
Benzinga Real-time News ·  2021/04/10 00:57

UPDATE: Pfizer-BioNTech Say Requests Based On Data From Pivotal Phase 3 Trial In Adolescents 12 To 15 Years Of Age With Or Without Prior Evidence Of Sars-Cov-2 Infection

更新：辉瑞-BioNTech表示，请求是基于12至15岁青少年关键阶段3期试验的数据，无论之前有没有SARS-CoV-2感染的证据

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发